208 related articles for article (PubMed ID: 33902689)
1. Comparative preventive efficacy of ProHeart
McTier TL; Holzmer S; Kryda K; Mahabir S; McCall JW; Trombley J; Maeder SJ
Parasit Vectors; 2021 Apr; 14(1):226. PubMed ID: 33902689
[TBL] [Abstract][Full Text] [Related]
2. Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
Kryda K; Holzmer S; Everett WR; McCall JW; Mahabir SP; McTier TL; Maeder SJ
Parasit Vectors; 2020 Jul; 13(1):339. PubMed ID: 32660542
[TBL] [Abstract][Full Text] [Related]
3. Preventive efficacy of six monthly oral doses of Simparica Trio
Myers JAE; Holzmer S; McCall JW; Mahabir SP; McTier TL; Maeder SJ; Kryda K
Parasit Vectors; 2022 Mar; 15(1):81. PubMed ID: 35277191
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy of ProHeart
Bowman DD; McTier TL; Adams EL; Mahabir SP; Login JA; Bidgood T; Woods DJ
Parasit Vectors; 2017 Nov; 10(Suppl 2):502. PubMed ID: 29143654
[TBL] [Abstract][Full Text] [Related]
5. ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months.
McTier TL; Kryda K; Wachowski M; Mahabir S; Ramsey D; Rugg D; Mazaleski M; Therrien C; Adams E; Wolff T; Bowman DD
Parasit Vectors; 2019 Jul; 12(1):369. PubMed ID: 31349867
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs.
McTier TL; Six RH; Pullins A; Chapin S; McCall JW; Rugg D; Maeder SJ; Woods DJ
Parasit Vectors; 2017 Nov; 10(Suppl 2):482. PubMed ID: 29143634
[TBL] [Abstract][Full Text] [Related]
7. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs.
Kryda K; Six RH; Walsh KF; Holzmer SJ; Chapin S; Mahabir SP; Myers M; Inskeep T; Rugg J; Cundiff B; Pullins A; Ulrich M; McCall JW; McTier TL; Maeder SJ
Parasit Vectors; 2019 Sep; 12(1):445. PubMed ID: 31506094
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis.
Blagburn BL; Arther RG; Dillon AR; Butler JM; Bowles JV; von Simson C; Zolynas R
Parasit Vectors; 2016 Apr; 9():191. PubMed ID: 27044379
[TBL] [Abstract][Full Text] [Related]
9. Microfilarial reduction following ProHeart® 6 and ProHeart® SR-12 treatment in dogs experimentally inoculated with a resistant isolate of Dirofilaria immitis.
McTier TL; Pullins A; Inskeep GA; Gagnon G; Fan H; Schoell A; Bidgood T; Login J; Meeus P
Parasit Vectors; 2017 Nov; 10(Suppl 2):485. PubMed ID: 29143650
[TBL] [Abstract][Full Text] [Related]
10. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
McTier TL; Six RH; Pullins A; Chapin S; Kryda K; Mahabir SP; Woods DJ; Maeder SJ
Parasit Vectors; 2019 Sep; 12(1):444. PubMed ID: 31506088
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of moxidectin, using various dose regimens, against JYD-34, a macrocyclic lactone resistant isolate of Dirofilaria immitis.
Martin EM; Mitchell EB; Yoon S; McCall JW; Fankhauser B; Mansour A; McCall S; Pollmeier M
Parasit Vectors; 2024 Apr; 17(1):176. PubMed ID: 38575969
[TBL] [Abstract][Full Text] [Related]
12. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
[TBL] [Abstract][Full Text] [Related]
13. The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations.
McCall JW
Vet Parasitol; 2005 Oct; 133(2-3):197-206. PubMed ID: 16198822
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of long-term monthly administration of ivermectin on the progress of naturally acquired heartworm infections in dogs.
Venco L; McCall JW; Guerrero J; Genchi C
Vet Parasitol; 2004 Oct; 124(3-4):259-68. PubMed ID: 15381305
[TBL] [Abstract][Full Text] [Related]
15. Examination of the "susceptibility gap" in the treatment of canine heartworm infection.
Bowman DD; Drake J
Parasit Vectors; 2017 Nov; 10(Suppl 2):513. PubMed ID: 29143689
[TBL] [Abstract][Full Text] [Related]
16. Shifting the paradigm in Dirofilaria immitis prevention: blocking transmission from mosquitoes to dogs using repellents/insecticides and macrocyclic lactone prevention as part of a multimodal approach.
McCall JW; Varloud M; Hodgkins E; Mansour A; DiCosty U; McCall S; Carmichael J; Carson B; Carter J
Parasit Vectors; 2017 Nov; 10(Suppl 2):525. PubMed ID: 29143678
[TBL] [Abstract][Full Text] [Related]
17. Does evaluation of in vitro microfilarial motility reflect the resistance status of Dirofilaria immitis isolates to macrocyclic lactones?
Maclean MJ; Savadelis MD; Coates R; Dzimianski MT; Jones C; Benbow C; Storey BE; Kaplan RM; Moorhead AR; Wolstenholme AJ
Parasit Vectors; 2017 Nov; 10(Suppl 2):480. PubMed ID: 29143656
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of a topical formulation of selamectin plus sarolaner in preventing the development of a macrocyclic lactone-resistant strain of Dirofilaria immitis in cats.
Pullins A; McTier TL; Mahabir S; DeRose G; Hedges L
Vet Parasitol; 2020 Jun; 282():109122. PubMed ID: 32460111
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs.
Alberigi B; Fernandes JI; Paiva JP; Mendes-de-Almeida F; Knackfuss F; Merlo A; Labarthe N
Parasit Vectors; 2020 Oct; 13(1):503. PubMed ID: 33023664
[TBL] [Abstract][Full Text] [Related]
20. Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio
Young LM; Wiseman S; Crawley E; Wallace K; Snyder DE
Parasit Vectors; 2021 May; 14(1):284. PubMed ID: 34044864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
